BNP PARIBAS FINANCIAL MARKETS - XTL BIOPHARMACEUTICALS LTD ownership

XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of XTL BIOPHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$269
+34.5%
300
+50.0%
0.00%
Q2 2023$2002000.00%
Other shareholders
XTL BIOPHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Noked Israel Ltd 198,888$471,0000.14%
Noked Capital LTD 198,888$471,0000.14%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 49,271$102,0000.00%
UBS Group AG 812$2,0000.00%
View complete list of XTL BIOPHARMACEUTICALS LTD shareholders